# Citius Oncology, Inc.: Form 8-K, filed Jun 18, 2024

- Company: [Citius Oncology, Inc.](/companies/ctor.md) (CIK 1851484)
- Form: 8-K
- Filed: 2024-06-18
- Accepted by EDGAR: Jun 18, 2024, 13:35 ET
- Period: 2024-06-17
- Accession: 0001493152-24-024236
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1851484/000149315224024236/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1851484/000149315224024236/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1851484/000149315224024236/form8-k.htm

Filed Jun 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-024236. Last ingested by Listed: Nov 14, 2026, 21:33 ET. No prices; not investment advice.
